Conor Killmurray

Children with higher birth weight and body mass index, as well as taller height, are at a greater risk of developing renal cell carcinoma later in life, according to new study findings.

The Food and Drug Administration approved chemotherapy injection Pemfexy for the treatment of patients with nonsquamous non-small cell lung cancer.

As interest grows in the use of cannabinoids for the management of cancer-related pain, a recent study shows that they do not provide a benefit in pain management for patients with advanced cancer using opioids.

From actress Shannen Doherty announcing she will continue to fight her stage 4 breast cancer to the Food and Drug Administration’s first hearing on asbestos testing in talc in 50 years, here’s what is making headlines in the cancer space this week.

Patients with stage 3 melanoma who had one or more circulating tumor cells were found to relapse sooner, providing physicians with an important biomarker to treat the likelihood of relapse.

The World Health Organization has announced a vaccination-based initiative to eliminate cervical cancer as a public health problem in low to middle income countries.

For World Cancer Day, here are 6 hot topics making an impact in the cancer space.

New research examining Surveillance, Epidemiology, and End Results (SEER) program data found that relying solely on this data may lead to underestimating the rising rate of colorectal cancer in patients aged 49 and 50.

From NFL Hall of Famer Kurt Warner leading a recognition service for cancer caregivers during the Super Bowl to Tylenol’s key ingredient possibly being added to California’s proposition 65 list for chemicals that may cause cancer, here’s what is making headlines in the cancer space this week.

Although the rate of colorectal and gastric cancers has decreased in the overall population, new study findings show a rise in young adults.

Patients with epithelioid sarcoma finally have a specific treatment after the FDA granted accelerated approval to Tazverik, providing new hope for the future of these patients.

Racial and ethnic disparities have long been a part of the early detection of breast cancer in women, but a new study finds that these disparities are also connected by a patient’s insurance coverage.

From the FDA issuing a safety alert on cybersecurity vulnerabilities to health care facility technology to former Bachelorette star Ali Fedotowsky revealing she has basal cell carcinoma, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved Tazverik for the treatment of patients with metastatic or locally advanced epithelioid sarcoma — marking the first treatment option specifically for these patients.

Marijuana is often linked to fighting cancer and its effects, but in the case of head and neck squamous cell carcinoma, researchers found that it may increase the progression of the disease.

More people than ever are beginning their medical journeys online as digital videos on cancer education are proven to be a useful tool that institutions should provide.

Despite differences in tumors, the addition of CDK 4/6 inhibitors to endocrine therapy showed a benefit in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer compared with endocrine therapy alone.

Patients with gastrointestinal stromal tumors have a new targeted therapy that looks to tackle secondary mutations after it showed a strong response rate in the clinic.

From the largest one-year cancer death rate drop in the US to Supreme Court Justice Ruth Bader Ginsburg announcing she is cancer-free for a fourth time, here’s what is making the headlines in the cancer space this week.

The Food and Drug Administration approved Ayvakit for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumor who exhibited a platelet-derived growth factor receptor alpha exon 18 mutation.

In a new study, researchers set out to prove whether or not there was a statistically significant risk of ovarian cancer from the use of talc-based powder.

A physician’s social network is important to determining the adoption of high-value cancer drugs, as researchers have determined peer influence had a strong association with the adoption of Avastin among oncologists across the nation.

A multiple myeloma expert helps newly diagnosed patients understand the standard of care for their disease.

Patients with multiple myeloma have a lot to look forward to in the treatment space thanks to precision medicine, but one treatment option alone will not cure the disease.

Fast track designation has been granted for the investigational therapy tipifarnib to treat patients with HRAS mutant head and neck squamous cell carcinomas.

New findings show that the socioeconomic status of children with AML plays a significant and alarming roll in the rate of their overall survival after diagnosis.

Baseline laboratory values for AML clinical trials are setting unnecessary restrictions for kidney function that excludes African American patients with AML when this comorbidity does not impact overall survival.

Patient advocate and lung cancer survivor Nancy Cohen discusses living with stage 4 lung cancer.